Head and Neck Cancer: New Imaging Technique

We are testing a new near-infrared imaging method to help surgeons detect remaining cancer cells during surgery. This study aims to improve the accuracy of tumor removal and preserve healthy tissue.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Infracyanine
Infracyanine is an eye surgery dye used to stain retinal tissues so surgeons can better see and remove abnormal membranes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Indocyanine Green
Indocyanine Green is a diagnostic dye used to visualize blood flow and tissue perfusion during imaging and surgical procedures.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Verdye

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Jules Bordet
Surgical Oncology
Negenmanneke, Belgium
Institut Gustave Roussy
Departement Cancerologie Cervico Facial
Villejuif, France
Sponsor: Institut Gustave Roussy
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.